BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7718898)

  • 1. Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II.
    Vieira LM; Kaplan JC; Kahn A; Leroux A
    Blood; 1995 Apr; 85(8):2254-62. PubMed ID: 7718898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (diaphorase 1) gene.
    Kugler W; Pekrun A; Laspe P; Erdlenbruch B; Lakomek M
    Hum Mutat; 2001 Apr; 17(4):348. PubMed ID: 11295830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b(5) reductase gene leading to methemoglobinemia type I.
    Dekker J; Eppink MH; van Zwieten R; de Rijk T; Remacha AF; Law LK; Li AM; Cheung KL; van Berkel WJ; Roos D
    Blood; 2001 Feb; 97(4):1106-14. PubMed ID: 11159544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia.
    Manabe J; Arya R; Sumimoto H; Yubisui T; Bellingham AJ; Layton DM; Fukumaki Y
    Blood; 1996 Oct; 88(8):3208-15. PubMed ID: 8874222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three novel mutations in CYB5R3 gene causing NADH-cytochrome b5 reductase enzyme deficiency leads to recessive congenital methaemoglobinemia.
    Deorukhkar A; Kulkarni A; Kedar P
    Mol Biol Rep; 2022 Mar; 49(3):2141-2147. PubMed ID: 35064402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutation (R192C) in CYB5R3 gene causing NADH-cytochrome b5 reductase deficiency in eight Indian patients associated with autosomal recessive congenital methemoglobinemia type-I.
    Kedar PS; Gupta V; Warang P; Chiddarwar A; Madkaikar M
    Hematology; 2018 Sep; 23(8):567-573. PubMed ID: 29482478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency.
    Katsube T; Sakamoto N; Kobayashi Y; Seki R; Hirano M; Tanishima K; Tomoda A; Takazakura E; Yubisui T; Takeshita M
    Am J Hum Genet; 1991 Apr; 48(4):799-808. PubMed ID: 1707593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial idiopathic methemoglobinemia revisited: original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase.
    Percy MJ; Gillespie MJ; Savage G; Hughes AE; McMullin MF; Lappin TR
    Blood; 2002 Nov; 100(10):3447-9. PubMed ID: 12393396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis.
    Aalfs CM; Salieb-Beugelaar GB; Wanders RJ; Mannens MM; Wijburg FA
    Hum Mutat; 2000; 16(1):18-22. PubMed ID: 10874300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum and molecular basis of recessive congenital methemoglobinemia in India.
    Warang PP; Kedar PS; Shanmukaiah C; Ghosh K; Colah RB
    Clin Genet; 2015; 87(1):62-7. PubMed ID: 24266649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant.
    Percy MJ; Crowley LJ; Roper D; Vulliamy TJ; Layton DM; Barber MJ
    Blood Cells Mol Dis; 2006; 36(1):81-90. PubMed ID: 16310381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia.
    Wang Y; Wu YS; Zheng PZ; Yang WX; Fang GA; Tang YC; Xie F; Lan FH; Zhu ZY
    Blood; 2000 May; 95(10):3250-5. PubMed ID: 10807796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygosity of two missense mutations in the NADH-cytochrome b5 reductase gene of a Polish patient with type I recessive congenital methaemoglobinaemia.
    Grabowska D; Plochocka D; Jablonska-Skwiecinska E; Chelstowska A; Lewandowska I; Staniszewska K; Majewska Z; Witos I; Burzynska B
    Eur J Haematol; 2003 Jun; 70(6):404-9. PubMed ID: 12756024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel point mutation (Leu72Pro) in the NADH-cytochrome b5 reductase gene of a patient with hereditary methaemoglobinaemia type I.
    Wu YS; Huang CH; Wan Y; Huang QJ; Zhu ZY
    Br J Haematol; 1998 Jul; 102(2):575-7. PubMed ID: 9695975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-frame deletion of codon 298 of the NADH-cytochrome b5 reductase gene results in hereditary methemoglobinemia type II (generalized type). A functional implication for the role of the COOH-terminal region of the enzyme.
    Shirabe K; Fujimoto Y; Yubisui T; Takeshita M
    J Biol Chem; 1994 Feb; 269(8):5952-7. PubMed ID: 8119939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase Gene.
    Forestier A; Pissard S; Cretet J; Mambie A; Pascal L; Cliquennois M; Cambier N; Rose C
    Hemoglobin; 2015; 39(6):438-41. PubMed ID: 26291966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type).
    Shirabe K; Yubisui T; Borgese N; Tang CY; Hultquist DE; Takeshita M
    J Biol Chem; 1992 Oct; 267(28):20416-21. PubMed ID: 1400360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and biological forms of cytochrome b5 reductase deficiency].
    Kaplan JC; Leroux A; Beauvais P
    C R Seances Soc Biol Fil; 1979; 173(2):368-79. PubMed ID: 159760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia.
    Shirabe K; Landi MT; Takeshita M; Uziel G; Fedrizzi E; Borgese N
    Am J Hum Genet; 1995 Aug; 57(2):302-10. PubMed ID: 7668255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel point mutation in NADH-cytochrome b5 reductase gene].
    Wang Y; Wu Y; Yang W
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):521-3. PubMed ID: 11721397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.